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Highly improved accuracy of the revised 
PREoperative sarcoma score (rPRESS) in the 
decision of performing surgery for patients 
presenting with a uterine mass
Tomonori Nagai*, Yasushi Takai, Taichi Akahori, Hiroaki Ishida, Tatsuya Hanaoka, Takahiro Uotani, Sho Sato, 
Shigetaka Matsunaga, Kazunori Baba and Hiroyuki Seki
Abstract 
In 2014, we published an article titled “Novel uterine sarcoma preoperative diagnosis score predicts the need for sur-
gery in patients presenting with a uterine mass” on the preoperative diagnosis of uterine sarcoma, in the SpringerPlus 
(Nagai et al. in SpringerPlus 2014, 3:678. doi:10.1186/2193-1801-3-678). Subsequently, we received several sugges-
tions from readers, which were used to modify the statistical analysis methods and create a more precise preopera-
tive diagnostic scoring system, which we present here as a supplemental report. The subjects were 63 patients who 
underwent surgical therapy for suspected uterine sarcoma (sarcoma group: 15 patients, benign group: 48 patients). 
Logistic regression analysis using the exact method was performed considering the subjects’ preoperative age, serum 
lactate dehydrogenase levels, magnetic resonance imaging findings, and endometrial cytology findings. We then 
used parameter estimates obtained from this analysis to revise the PREoperative Sarcoma Score (PRESS). The revised 
PRESS (rPRESS) has a maximum score of 10 points and an optimal cut-off value of 4 points, as derived from a receiver 
operating characteristic curve. Using this, the accuracy, positive predictive value, and negative predictive value were 
93.7, 92.3, and 94.0 %, respectively. The diagnostic precision of the rPRESS is better than that of the original PRESS.
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Background
Uterine sarcoma is a non-epithelial malignant tumor 
that occurs in the uterus. It is resistant to chemotherapy 
and radiation therapy. The prognosis is extremely poor, 
except in cases in which early radical resection is possi-
ble (Gadducci et  al. 2008). As the mass grows from the 
myometrium, approaching it from outside the body and 
making a pathological diagnosis from a biopsy can be dif-
ficult. Thus, the early diagnosis of uterine sarcoma often 
requires a hysterectomy and a pathological search. Preop-
erative diagnosis for uterine sarcoma using imaging and 
hematological findings has not exhibited a high accuracy. 
Therefore, many patients who undergo hysterectomy on 
a suspicion of uterine sarcoma are finally diagnosed with 
benign uterine myoma, the most common uterine mass. 
Only few patients are diagnosed with uterine sarcoma.
To improve the preoperative diagnosis of uterine sar-
coma, we previously created and reported a preoperative 
diagnostic scoring system (called the PREoperative Sar-
coma Score: PRESS) using several diagnostic predictive 
factors (Nagai et  al. 2014). In the PRESS, we selected 4 
diagnostic predictive factors from preoperative clini-
cal, hematological, imaging, and endometrial cytology 
findings. Preoperative age, serum lactate dehydrogenase 
(LDH) levels, magnetic resonance imaging (MRI) find-
ings, and endometrial cytology findings were used to cre-
ate a preoperative diagnosis scoring system for uterine 
sarcoma. At its optimal cut-off value, the scoring system 
had an accuracy of 84.1 %, sensitivity of 0.8, and specific-
ity of 0.854.
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Readers commented on the article and suggested that 
the diagnostic accuracy of PRESS could be improved by 
modifying the statistical analysis method. They suggested 
that using the exact method instead of the maximum 
likelihood method with logistic regression analysis for 
the multivariate analysis would improve the accuracy of 
the analysis.
The maximum likelihood method is often used with 
parameter estimates in logistic regression analyses. How-
ever, when the occurrence probability is extremely small 
(or large), or if the number of samples is not enough for 
the number of parameters, it is sometimes impossible to 
obtain accurate estimates with this method. The exact 
method is one way of resolving these issues (Mehta and 
Patel 1995) (Heinze and Schemper 2002).
The present study used the subjects from our previous 
report (63 patients who underwent surgery based on a 
preoperative suspicion of uterine sarcoma). Four diag-
nostic predictive factors that exhibited significant differ-
ences in the univariate analyses (preoperative age, serum 
LDH level, MRI findings, and endometrial cytology find-
ings) were used in multivariate analyses using a logistic 
regression analysis with the exact method. The results 
of these analyses were used to create the revised PRESS 
(rPRESS). We found that the rPRESS had a higher accu-
racy in the preoperative diagnosis of uterine sarcoma. 




The subjects were the 63 patients from a previous report 
titled “Novel uterine sarcoma preoperative diagnosis 
score predicts the need for surgery in patients presenting 
with a uterine mass” (Nagai et  al. 2014). These patients 
underwent surgery at the Saitama Medical Center of 
Saitama Medical University, between January 2006 and 
December 2012. Among them, 15 patients had uterine 
sarcoma and 48 patients had benign uterine tumor repre-
sented by uterine myoma (Table 1).
This study complied with the guidelines specified in 
the Declaration of Helsinki and Japanese ethical guide-
lines for observational studies. Therefore, this study 
was approved by the Institutional Review Board (IRB) 
of Saitama Medical Center, Saitama Medical University, 
without the necessity to obtain written informed consent 
from the patients for the publication of this report.
Statistical analysis
A logistic regression analysis using the exact method was 
performed on the predictive factors that exhibited sig-
nificant differences in the univariate analyses preformed 
in our previous report (age, serum LDH levels, MRI 
findings, and endometrial cytology findings). The param-
eter estimates obtained from this were used to create the 
rPRESS. The cut-off values for the rPRESS were derived 
from a receiver operating characteristic (ROC) curve. 
P < 0.05 was considered statistically significant. The SAS 
system was used for the statistical analyses.
Results and discussion
In our previous report (Nagai et  al. 2014), univariate 
analyses revealed that age, serum LDH levels, MRI find-
ings, and endometrial cytology findings were significant 
factors in the preoperative prediction of uterine sar-
coma. The cut-off values for age and serum LDH lev-
els were 49  years and 279 U/L, respectively. A positive 
MRI finding was, “intratumoral hyperintense signal on 
T1-weighted images and/or a heterogeneous signal on 
T2-weighted images.” For endometrial cytology classified 
using the Papanicolaou classification, a Class III or higher 
was considered as a positive finding. If Class III or higher 
was observed, an endometrial biopsy was performed. 
Patients who were diagnosed with a malignant tumor at 
this point were excluded from the present study. Table 2 
shows the preoperative data for the predictive factors in 
the sarcoma and benign groups.
In the present study, we performed a logistic regres-
sion analysis on these 4 factors, using the exact method, 
which found age, serum LDH levels, and endometrial 
cytology findings to be independent predictive fac-
tors (Table  3). We repeated the logistic regression 
analysis with the exact method on these 3 factors, to cal-
culate parameter estimates (Table  4). We then created 
the rPRESS by referencing these parameter estimates. In 
the rPRESS, age ≥49  years is assigned 2 points, serum 
LDH level ≥279 U/L is assigned 4 points, and positive 
endometrial cytology is assigned 4 points, leading to a 
total of 10 points (Table  5). MRI findings were consid-
ered a scoring item in the original PRESS. However, as 
the multivariate analysis did not show them to be an 
Table 1 Histological analysis
Pathological diagnosis
 Sarcoma (n = 15)
  Leiomyosarcoma 9 (60.0 %)
  Adenosarcoma 3 (20.0 %)
  ESS 3 (20.0 %)
 Benign (n = 48)
  Cellular leiomyoma 4 (8.3 %)
  Leiomyoma 42 (87.5 %)
  Adenomyosis 2 (4.2 %)
Total 63
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independent predictive factor, they were eliminated 
from the revised version. Regarding point distribution, 
in the original PRESS, age, serum LDH levels, and endo-
metrial cytology findings were assigned 2 points each, 
because they displayed significant differences in both the 
univariate and multivariate analyses, while MRI findings 
only received 1 point as they exhibited a significant dif-
ference only in the univariate analysis. In the rPRESS, 
the point distribution was based on the parameter esti-
mates obtained from the logistic regression analysis 
using the exact method.
With the rPRESS, mean scores of 5.067 and 0.792 were 
obtained in the sarcoma and benign groups, respectively, 
indicating a significant difference. With an ROC curve, 
the statistically optimal cut-off value for the rPRESS was 
4 points (Fig. 1). When the score was 4 points or higher 
on the rPRESS, the accuracy, positive predictive value 
(PPV), negative predictive value (NPV), sensitivity, and 
specificity were 93.7, 92.3, 94.0 %, 0.8, and 0.979, respec-
tively (Table 6).
However, 3 cases with a rPRESS score of less than 4 
points eventually received pathological diagnoses of 
uterine sarcoma (all scored 2 points). One of them was 
a 51-year-old post-menopausal woman who complained 
of lower abdominal pain. A 9-cm intrauterine tumor was 
found. The patient’s serum CA125 level was elevated (180 
U/mL), but RI was low (0.39). No abnormalities were 
observed in serum LDH level, MRI findings, or endo-
metrial cytology findings. The final pathological diag-
nosis after hysterectomy was ESS. The patient’s original 
PRESS score was also 2 points, and she was assessed to 
Table 2 Positive findings in patients
* P < 0.05
Total Sarcoma Benign P value (sar. vs. ben.) Sensitivity Specificity PPV (%) NPV (%)
Age (≥49 years) 31/63 (49.2 %) 14/15 (93.3 %) 17/48 (35.4 %) <0.001* 0.93 0.65 45.2 96.9
Serum LDH level (≥279 U/L) 7/63 (11.1 %) 7/15 (46.7 %) 0/48 (0.0 %) <0.001* 0.47 1.00 100.0 85.7
MRI findings 27/63 (42.9 %) 12/15 (80.0 %) 15/48 (31.3 %) <0.001* 0.80 0.69 44.4 91.7
Cytological findings 6/63 (9.5 %) 5/15 (33.4 %) 1/48 (2.1 %) <0.001* 0.33 0.93 83.3 58.3
Table 3 Multivariate analysis of  statistically significant 
positive findings
* P < 0.05
Odds ratio 95 % CI p value
Age 10.139 [1.639, ∞] 0.033*
Serum LDH level 36.988 [5.140, ∞] <0.001*
MRI findings 0.498 [0.009, 7.114] 0.981
Cytological findings 42.527 [5.988, ∞] <0.001*
Table 4 Parameter estimates of each predictor
* P < 0.05
Odds ratio 95 % CI P value Parameter 
estimates
Age 9.159 [1.517, ∞] 0.039* 2.215
Serum LDH level 38.108 [6.215, ∞] <0.001* 3.640
Cytological find-
ings
41.040 [6.518, ∞] <0.001* 3.715
Table 5 The revised PREoperative sarcoma scoring system 
(rPRESS)
Predictors 0 point 2 points 4 points
Age <49 ≥49
Serum LDH level <279 ≥279
Cytological findings Negative Positive
Total 10 points
Fig. 1 ROC curve for rPRESS. The optimum cut-off point based on 
the ROC curve analysis for the rPRESS was 4 points
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be negative. In addition, a 12-cm uterine tumor was 
found in a 71-year-old woman with abnormal vaginal 
bleeding. The intratumoral RI showed a low value (0.25), 
but the serum LDH level, MRI finding, and endometrial 
cytology finding showed no abnormality. After hyster-
ectomy, the final pathological diagnosis was leiomyosar-
coma. This patient’s original PRESS score was also 2, and 
she was assessed to be negative. The third patient was 
a 73-year-old woman with abnormal vaginal bleeding. 
She was found to have a 7-cm uterine tumor on MRI, 
suspected to be a uterine sarcoma. However, her serum 
CA125 level, serum LDH level, and endometrial cytology 
results were normal. The final postoperative pathologi-
cal diagnosis was leiomyosarcoma. Her original PRESS 
score was 3, and owing to positive MRI findings, she was 
assessed to be positive. Using a cut-off value of 4 points 
would have missed these 3 cases. Considering that uter-
ine sarcoma is a malignant tumor with poor prognosis, 
missed diagnoses are unacceptable. Therefore, our inves-
tigations suggest that surgery should be performed for a 
pathological diagnosis when the rPRESS score is 2 points 
or higher. This diagnostic score is ultimately only a refer-
ence in deciding the treatment plan, and the final deci-
sion on whether to operate should be made carefully for 
each individual case. In addition, considering the serum 
CA125 level, MRI findings, and intratumoral RI value, 
which were not used as predictive factors in the present 
study, further examination with a greater number of 
cases is necessary.
Recently, laparoscopic hysterectomy or myomectomy 
have become common forms of minimally invasive sur-
gery for uterine myoma, which is a benign disease. How-
ever, the morcellation that occurs during such surgeries 
may accidently cause uterine sarcoma lesions to scatter 
in the abdominal cavity (Brower 2014) (Senapati et  al. 
2015). The rPRESS scoring system was created to act as a 
tool to select, as carefully as possible, cases in which uter-
ine sarcoma is suspected before surgery. However, it may 
be useful as a preoperative screening tool to eliminate the 
possibility of performing laparoscopic surgeries intended 
to address what are thought to be benign uterine myoma, 
in cases where the disease is actually malignant. How-
ever, this scoring system was created as a tool for retro-
spectively examining data in particular cases in which 
uterine sarcoma is suspected before surgery. Therefore, 
it is not necessarily applicable as is for uterine sarcoma 
suspected to be benign uterine myoma. Consequently, 
further examinations are necessary to determine whether 
this scoring system is a valid screening tool when applied 
to multiple cases of uterine tumor thought to be benign 
uterine myoma before surgery.
Conclusion
We found that the rPRESS had a better diagnostic accu-
racy and was more useful than the original PRESS. The 
rPRESS could help determine treatment plans for uterine 
masses suspected of being uterine sarcoma.
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Table 6 The revised PREoperative sarcoma score (rPRESS) and accuracy of rPRESS for all patients
Scoring (points) 0 2 4 6 8 10 Total Mean score (range)
Sarcoma 0 3 1 11 0 0 15 5.067 (2–6)
Benign 30 17 1 0 0 0 48 0.792 (0–4)
Total 30 20 2 11 0 0 63 1.810 (0–6)
P < 0.001 (sar. vs. ben.)
Scoring (points) ≥0 ≥2 ≥4 ≥6 ≥8 ≥10
Sarcoma 15 15 12 11 0 0
Benign 48 18 1 0 0 0
Total 63 33 13 11 0 0
Accuracy (%) 23.8 71.4 93.7 93.7 76.2 76.2
PPV (%) 23.8 45.5 92.3 100 – –
NPV (%) – 100 94.0 92.3 76.2 76.2
Sensitivity 1 1 0.8 0.733 0 0
Specificity 0 0.625 0.979 1 1 1
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